Trial Profile

A phase II Human Challenge Trial (HCT) of VXA-CoV2-1

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 21 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs VXA CoV2-1 (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use

Most Recent Events

15 Mar 2023 According to a Vaxart media release, company is postponing further COVID-19 clinical trials, including this Omicron Human Challenge Trial in the UK.
08 Aug 2022 According to a Vaxart media release, the company expects to initiate this study in the UK starting in the 2H 2023.
13 Jul 2022 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com